gvtcx

UCLH-6630 - LECANEMAB HOMECARE SERVICE

University College London Hospitals NHS Foundation Trust Published 5 Mar 2025 Contracts Finder

key details

Value£816,000
Statusactive
Category (CPV) 85149000
Deadline26 Mar 2025
Contract start3 Nov 2025
Contract end2 Nov 2027
Procedureopen
SME suitableNo
OCIDocds-b5fd17-b0293d34-ece5-4549-9adc-6d396d33200a

description

The service requirements for the direct supply and administration of Lecanemab (Leqembi) in a patient's home, via a homecare delivery service. Lecanemab is indicated for the treatment of mild cognitive impairment and mild dementia due to Alzheimer's disease in adult patients that are apolipoprotein E ε 4 (ApoE ε 4) heterozygotes or non-carriers. The service is being offered by UCLH private Healthcare and will be for private patients only. The requirement is for a private homecare provider situated in the UK to provide this service.

Additional information:

To express interest and participate in the tender, please register and apply via Atamis e-sourcing portal https://health-family.force.com/s/Welcome.

Should Tenderers have any queries, or having problems using the portal, they should contact Helpdesk at:

Phone: 0800 9956035

E-mail: support-health@atamis.co.uk

documents

Documents are linked, not mirrored. They are served by the publishing authority and may require registration.

notice history

1 notice published against this procurement.

PublishedTypeRegimeNotice
5 Mar 2025 Tender (tender) · e93c035b-9514-44f6-b461-5f0e6cc4b49b-832083

more from University College London Hospitals NHS Foundation Trust

all contracts from this buyer →

similar contracts awarded

Other awarded contracts in the same category. Useful for seeing who normally wins this kind of work, and at what value.

source

Published on Contracts Finder. Contact details for named individuals are not reproduced on this site.